Fostamatinib, which is used for rheumatoid arthritis and immune thrombocytopenic purpura (ITP) treatment74,75, can also be used as a potential inhibitor of pdgfrb and kit76. Here, PDGFRB is linked to autoimmune thrombocytopenic purpura.